38351 Immune-related adverse events in cancer patients receiving immune checkpoint inhibitors

ABSTRACT IMPACT: The existing literature describing immune-related adverse events (irAE) has predominantly focused on clinical trial populations, which may not be representative of the broader population receiving immune checkpoint inhibitors (ICI), so we sought to perform a comprehensive evaluation...

Descripción completa

Detalles Bibliográficos
Autores principales: Lucas, Margaret Byrnethew, Pai, Lori, Breeze, Janis, Parsons, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Translational Science, Policy, & Health Outcomes Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827839/
http://dx.doi.org/10.1017/cts.2021.698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827839/
http://dx.doi.org/10.1017/cts.2021.698

Ejemplares similares